We have evaluated the determination of lactate dehydrogenase (EC 1.1.1.27) isoenzyme 1 activity by chemical inhibition of the other isoenzymes with perchiorate and with 1,6-hexanedioi. In the hexanediol method, we studied the effect of the duration of incubation with the inhibitor; a 5-mm incubation yieldedresults closestto those of an immunochemical technique (Isomune-LD). The perchlorate method was the most precise, and the hexanediol method the least, although for none of the techniques did the coefficient of variation exceed the medically acceptable limit prescribed by the College of American Pathologists. Pairwise correlation among the immunoprecipitation, electrophoretic, and chemical inhibition methods was good (r>0.991), although the differences between means were statistically significant (except for the comparison of the two chemical inhibition methods). Because of its ease, low cost, and precision, we recommend the perchiorate method for routine use.
Usategui-Gomez et al.
(1) described a technique for isolating isoenzyme 1 of lactate dehydrogenase (LD, EC 1.1.1.27), based on immunoprecipitation of the M monomer and subsequent determination of residual LD activity in the supernate. This method has been extensively evaluated analytically and clinically (2-6) and its reliability is considered well established. Its routine application to large series is unfortunately hindered by its cost and by the need for pre-treatment of samples.
Two other methods that have recently been proposed for determination of LI) 1 are both based on chemical inhibition of other LD isoenzymes, in one case by 1,6-hexanediol (7)and in the other by perchlorate (8). Both these methods are much less expensive than immunochemical or electrophoretic techniques, and encouraging results have been reported for both, but neither has yet been evaluated sufficiently; little work has been published on them, primarily, as far as we know, only among the abstracts of congresses (8-10). In this communication we report the results of a study carried out to compare these two chemical inhibition methods with the immunoprecipitation method (used as a reference) and with the eleetrophoretic technique, which is still widely used in clinical laboratories for studying U) isoenzymes. Hexanediol method. For determining LD 1 by the hexanediol method in the Hitachi 737, we added 50 L of a 3.5 mol/L solution of 1,6-hexanediol (from E. Merck) to 200 L of serum to reach the recommended final concentration of 0.7 molJL (7).Samples treated with hexanediol were incubated at 30#{176}C for 5 or 15 mm, then placed in a water! icefNaCl bath untilfinalmeasurement (within the next 15 mm; when this time limit could not be met, we stored the whole system in a refrigerator at 4 #{176}C).
Materials and Methods

Analytical Procedures
Subjects
The reference intervals for the various methods were established with the aid of 100 healthy volunteer blood donors (47 men and 53 women, ages i7-64y, median 33y). For the rest of the study we used 104 samples collected from patients in the first three days after acute myocardial infarction. Inhibition with perchiorate. We confirmed that perchlorate reduces the affinity of LD 1 for pyruvate. Table 1 lists the results of enriching the medium with various concentrations ofpyruvate. The optimal concentration of pyruvate under the working conditions used is in the range 104-154 mmol/L, whereas a concentration of 200 mmoIIL lowered the LD activity measured.
Statistical
The stability of the LD activity determination reagent with perchlorate was studied by using the same reagent to analyze 21 serum samples at various times after addition of the perchlorate. The results (Table 2) show that the reagent with perchlorate is stable for at least 48 h (the reagent without perchlorate is stable for four days).
To determine whether LD 1 is partly inhibited by perchlorate, we kept 20 serum samples for 1 h at 65 #{176}C, which inactivates all LD isoenzymes except LD 1 (13) (we verified this electrophoretically), then determined U) with and without perchlorate.
The mean inhibition of U) 1 by perchlorate was 32%. Inhibition with hexanediol. Table 3 lists the results obtained when samples incubated for 15 mm with hexanediol were subsequently subjected to various conditions (the samples kept at 4#{176}C were not the same as those kept at room temperature); similar results were obtained after 5 mm of incubation. At room temperature activity declined rapidly; therefore the length of time between incubation with hexanediol and determination is critical.
Comparison of the results obtained by incubating samples with hexanediol for 5 mm as described by Shamberger (9), and for 15 mm as described by Tanishima et al. Precision studies. Table 4 shows the precision of the immunoprecipitation, electrophoretic, perchlorate, and hexanediol methods. In no case did the coefficient of variation exceed the medically tolerable limit recommended by the College of American Pathologists (cited in 14). Correlation among methods. Figure 1 shows the correlation between the inununoprecipitation method and the two chemical inhibition methods, and the correlationbetween the two chemical inhibition methods. ods were established with samples from 100 clinically healthy adults. After normalization of the distributions, these ranges were 41-98 UIL for the immunoprecipitation method (22.8-37.3% oftotal LD concentration); 38-92 UIL for the electrophoretic method (21.0-36.2% of total U)); 42-101 UIL for the perchlorate method (22.7-39.0% of total LD); and 41-100 UIL for the 5-mm hexanediol method (22.7-39.3% of total LD).
Patients.
When LD 1 and total LD activities were determined in samples from patients in the first three days after acute myocardial infarction, none of the methods used gave false negatives based on the U) 1 results expressed in UIL. However, when LD 1 activity was expressed as a percentage of total LD activity, results were falselynegative for patients who in addition had severe hepatic complications (biochemically verified). #{176} With 5-mm incubation.
Discussion
The fact that perchlorate reduces the affinity of LD 1 for pyruvate means that the concentration of substrate in the reagent must be increased from the original 3.64 mmol/L to 104-154 mmol/L. Abbott and Byrne (8) reported a similar perchlorate-induced reduction of the affinity of LD for lactate. The addition of perchlorate also reduces the useful life of the reagent from four to two days, but this may be acceptable for routine assay.
For incubating samples with inhibitor in the hexanediol method, the 5-mm incubation recommended by Shamberger (9) was preferred to the 15-min recommended by Tanishima et al. (7),yielding results that were closer to those of the immunoprecipitation method.
Like Tanishima et al. (7),we found that, because of loss of U) activity, the time elapsed between incubation with hexanediol and the determination of activity is crucial. However, we also found that standardization of the method was improved by using an ice-bath to bring the samples to 0#{176}C immediately after incubation (whether a 5-or 15-mn incubation).
The imprecisions of the iminunochemical and chemical inhibition methods were not clinically significant. The perchlorate method was the most precise and the hexanediol method the least.
All the methods correlated well with each other (Table  5 ), but the differences among their means exceeded the medically tolerable error specified by the College of American Pathologists (cited in 14) , except for the difference between the means of the two chemical inhibitions methods. These discrepancies among the means appear to be largely due to the high mean activity of the set of samples used, because the similarity among the results of the various methods for activities in the reference range suggests that for such values the differences among the methods may be clinically acceptable. It is well known that similarities (or even identities) in reference intervals do not imply that different methods will have similar (or identical) performance in patients with abnormal contents/activities of analytes.
Despite good correlation, the various methods may of course measure different fractions of total LD.
The findings of Siede et al. (10) appear to show that the inhibition of LD isoenzymes by perchlorate is total except for U) 1. However, in the present study, the perchlorate method afforded lower LD 1 activities than the immuneprecipitation method, suggesting that LD 1 too is partly inhibited by perchlorate.
The 32% inhibition of LD 1 by perchlorate was much more than was expected, in view of the earlier differences with respect to the immunochemical method ( Figure 1 ). Perhaps the prior heat treatment altered the structure of LD 1 sufficiently to increase its susceptibility to perchlorate. Electrophoretic fractionation of severalsamples incubated with hexanediol for 5, 10, or 15 min showed that all had a small residual LD 2 activity, although this declined as the incubation time increased. The fact that the hexane-.diol method afforded lower LD 1 activities than the immunoprecipitation method therefore suggests that LD 1 also is partly inhibited by hexanediol.
In view of all the above findings, we conclude that its ease, low cost, and precision make the perchlorate method a suitable technique for routine analysis for LD in a large series of serum samples. Using readily available biochemical assays of plasma and urine constituents, we have defined discriminant functions useful as a guide to the differential diagnosis of patients with hypercalcemia. The decreasingrankorderofcontribution of the variables to the discriminant functions was as follows: plasma albumin, plasma phosphate, plasma chloride, log10 (calcium excretion per liter of glomerular filtrate), and Iog (plasma gamma-glutamyltransferase). Discriminant functions have been defined for patients with values for plasma creatinine above and below 185 &niol/L, and for practical conditions in which plasma and urine samples, or plasma samples only, are available. We have re-investigated the use of discriminant func-
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